Xentria
Phase 2Xentria is a biotech company building authentic life-sciences partnerships to guide innovative drug and intellectual property development from early concepts through clinical development and towards commercial launch.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Xentria is a biotech company building authentic life-sciences partnerships to guide innovative drug and intellectual property development from early concepts through clinical development and towards commercial launch.
AntibodiesBiologicsBiosimilars